A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
Condition(s):PsoriasisLast Updated:February 8, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):PsoriasisLast Updated:February 8, 2024Active, not recruiting
Condition(s):Palmoplantaris PustulosisLast Updated:March 5, 2024Completed
Condition(s):PsoriasisLast Updated:May 13, 2020Completed
Condition(s):PsoriasisLast Updated:December 7, 2023Terminated
Condition(s):Bechet’s DiseaseLast Updated:April 29, 2020No longer available
Condition(s):PsoriasisLast Updated:May 7, 2020Completed
Condition(s):PsoriasisLast Updated:April 24, 2020Completed
Condition(s):PsoriasisLast Updated:March 5, 2024Completed
Condition(s):PsoriasisLast Updated:December 12, 2022Completed
Condition(s):Behçet’s SyndromeLast Updated:July 22, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.